Secreted Factors from Dental Pulp Cells Reduce Stroke Damage in Mice

In a mouse model of ischemic stroke and in hypoxic microglial cells, researchers evaluated a cell-free therapy made from factors released by human dental pulp stem cells. The treatment lowered infarct size and markers of neuronal death, oxidative stress, and inflammation, while promoting a reparative microglial state and improving neurogenesis, vascular changes, and synaptic structure. These cellular effects accompanied better motor coordination, learning, memory, and anxiety-related behavior.

Because transplanted stem cells appear to work through a brief burst of signaling rather than lasting survival, scientists are testing cell-free treatments. These are made by culturing stem cells, collecting the secreted molecules and vesicles, and delivering that material instead of the cells themselves.

Dental pulp stem cell secretions contain neurotrophic, antioxidant, and immune-modulating factors. In a mouse stroke model and hypoxic microglial cells, this secretome reduced infarct size, neuronal death, oxidative stress, and inflammatory signaling, while promoting a reparative microglial profile and improving neurogenesis, vascular remodeling, and synaptic organization. These changes accompanied better motor coordination, learning, memory, and anxiety-related behavior.